Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: An analysis based on a large diabetes registry in Germany and Austria

Pediatric Diabetes

Volumn 16, Issue 7, 2015, Pages 529-537

  Konrad, Katja ^a   Datz, Nicolin ^b   Engelsberger, Ilse ^c   Grulich Henn, Jürgen ^d   Hoertenhuber, Thomas ^e   Knauth, Burkhild ^b   Meissner, Thomas ^f   Wiegand, Susanna ^g   Woelfle, Joachim ^h   Holl, Reinhard W ⁱ  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Auf der Bult Hannover ^*  (Germany)

^c Klinikum Schwabing   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF BONN   (Germany)

ⁱ UNIVERSITY OF ULM   (Germany)

Author keywords

BMI; Diabetes registry; Glycated hemoglobin; Insulin resistance; Metformin; PCOS

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; AUSTRIA; BODY MASS; CHILD; CONTROLLED STUDY; DRUG USE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GERMANY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MONOTHERAPY; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SCHOOL CHILD; BLOOD; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION DRUG THERAPY; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; INSULIN RESISTANCE; LONGITUDINAL STUDY; METABOLISM; MULTICENTER STUDY; OVERWEIGHT; PREVALENCE;

ADOLESCENT; AUSTRIA; BODY MASS INDEX; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FEMALE; GERMANY; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; METFORMIN; OVERWEIGHT; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84942980545     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12203     Document Type: Article

References (43)

1. Jones KL et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002: 25: 89-94.
2. Rosenbloom AL et al. Type 2 diabetes in children and adolescents. Pediatr Diabetes 2009: 10 (Suppl. 12): 17-32.
3. Copeland KC et al. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics 2013: 131: 364-382.
4. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996: 334: 574-579.
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998: 352: 854-865.
6. Moran A et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999: 48: 2039-2044.
7. Wiegand S et al. Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy. Eur J Endocrinol 2008: 158: 543-549.
8. Amiel SA et al. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991: 72: 277-282.
9. Caprio S et al. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. Am J Physiol 1994: 266: 885-891.
10. Domargard A et al. Increased prevalence of overweight in adolescent girls with type 1 diabetes mellitus. Acta Paediatr 1999: 88: 1223-1228.
11. Moon RJ, Bascombe LA, Holt RI. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes Obes Metab 2007: 9: 143-145.
12. Arslanian SA, Heil BV, Becker DJ, Drash AL. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991: 72: 920-926.
13. Steigleder-Schweiger C et al. Prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes in Austria. Eur J Pediatr 2012: 171: 1193-1202.
14. Faienza MF et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci 2013: 10: 338-343.
15. Abdelghaffar S, Attia AM. Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents. Cochrane Database Syst Rev 2009: 1: CD006691.
16. Hamilton J et al. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 2003: 26: 138-143.
17. Sarnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol 2003: 149: 323-329.
18. Gin H et al. Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients. Metabolism 1985: 34: 923-925.
19. Pagano G et al. Metformin reduces insulin requirement in type 1 (insulin-dependent) diabetes. Diabetologia 1983: 24: 351-354.
20. Holterhus PM, Beyer P, Bürger-Büsing J et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Kirchheim Verlag 2009: 1-223.
21. Brufani C et al. Use of metformin in pediatric age. Pediatr Diabetes 2011: 12: 580-588.
22. Nadeau KJ et al. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study. Pediatr Diabetes 2014: doi: 10.1111/pedi.12140.
23. Kromeyer-Hauschild K et al. Perzentile für Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001: 149: 807-818.
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004: 114: 555-576.
25. Clarke W et al. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009: 10 (Suppl. 12): 134-145.
26. Gerstl EM et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27, 035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 2008: 167: 447-453.
27. Urakami T et al. Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus. Pediatr Int 2005: 47: 430-433.
28. Rosenbauer J et al. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012: 35: 80-86.
29. Dunger DB. Diabetes in puberty. Arch Dis Child 1992: 67: 569-570.
30. Holl RW et al. Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia 1998: 41: 542-547.
31. Dunger D, Ahmed L, Ong K. Growth and body composition in type 1 diabetes mellitus. Horm Res 2002: 58 (Suppl. 1): 66-71.
32. Fröhlich-Reiterer EE, Rosenbauer J, Bechthold-Dalla Pozza S, Hofer SE, Schober E, Holl RW. Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey. Arch Dis Child 2014: 99: 738-743 [Epub ahead of print].
33. Codner E, Escobar-Morreale HF. Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2007: 92: 1209-1216.
34. Codner E, Cassorla F. Puberty and ovarian function in girls with type 1 diabetes mellitus. Horm Res 2009: 71: 12-21.
35. Lund SS et al. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes. Diabetes Obes Metab 2009: 11: 966-977.
36. Schwab KO et al. Spectrum and prevalence of atherogenic risk factors in 27, 358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006: 29: 218-225.
37. Sorof JM et al. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003: 111: 61-66.
38. Margeirsdottir HD et al. Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care 2010: 33: 2043-2048.
39. Marcovecchio ML, Chiarelli F. Microvascular disease in children and adolescents with type 1 diabetes and obesity. Pediatr Nephrol 2011: 26: 365-375.
40. Giannini C et al. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev 2011: 27: 436-460.
41. Hawkins FP. Metformin and placebo therapy in adjunct with lifestyle intervention both improve weight loss and insulin resistance in obese adolescents. Arch Dis Child 2011: 97: 79-80.
42. Spaans EA et al. Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based. Ned Tijdschr Geneeskd 2011: 155: A3166.
43. Wiegand S et al. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. Eur J Endocrinol 2010: 163: 585-592.